• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Glycerolipids Glycerol ethers

Introduction to 1-o-hexadecyl-2-o-methyl-rac-glycerol (CAS No. 111188-59-1)

1-o-hexadecyl-2-o-methyl-rac-glycerol is a specialized glycerol derivative that has garnered significant attention in the field of pharmaceutical chemistry and biochemistry due to its unique structural properties and potential applications. This compound, identified by the CAS number 111188-59-1, belongs to a class of molecules known for their role in lipid metabolism and membrane interactions. Its molecular structure, featuring a long aliphatic chain and specific functional groups, makes it a candidate for various biochemical studies and therapeutic developments.

The compound’s primary structure consists of a glycerol backbone with an o-hexadecyl substituent at the first carbon position and an o-methyl group at the second carbon position. This configuration imparts distinct physicochemical properties, including solubility characteristics and reactivity profiles, which are critical for its utility in synthetic biology and drug formulation. The presence of a long hydrophobic chain enhances its interaction with lipid bilayers, making it a promising candidate for drug delivery systems targeting membrane-bound receptors or intracellular compartments.

Recent advancements in the field of lipid-based drug delivery have highlighted the importance of glycerol derivatives in enhancing bioavailability and improving pharmacokinetic profiles. Studies have demonstrated that compounds with similar structural motifs can facilitate the translocation of hydrophobic molecules across biological membranes, thereby increasing their therapeutic efficacy. 1-o-hexadecyl-2-o-methyl-rac-glycerol has been explored in preliminary research as a potential component in nanoformulations, such as liposomes or micelles, which are designed to improve the solubility and targeted delivery of poorly soluble drugs.

In addition to its role in drug delivery, this compound has shown promise in biochemical research as a substrate or intermediate in synthetic pathways. The unique reactivity of its glycerol backbone allows for modifications that can be tailored for specific biological applications. For instance, researchers have investigated its use in the synthesis of complex lipid molecules that mimic natural phospholipids, which are essential components of cell membranes. Such modifications could lead to novel therapeutic agents targeting membrane-related diseases or conditions.

The pharmacological potential of 1-o-hexadecyl-2-o-methyl-rac-glycerol has also been examined in the context of metabolic disorders. Preliminary studies suggest that this compound may influence lipid metabolism by interacting with key enzymes or receptors involved in fat storage and utilization. Given the rising prevalence of metabolic syndromes, such as obesity and type 2 diabetes, compounds like this could offer new avenues for therapeutic intervention. Further research is needed to fully elucidate its mechanisms of action and potential side effects.

From a synthetic chemistry perspective, 1-o-hexadecyl-2-o-methyl-rac-glycerol serves as an interesting building block for more complex molecules. Its stability under various reaction conditions makes it suitable for multi-step syntheses without significant degradation. This characteristic is particularly valuable in industrial settings where reproducibility and yield are critical factors. Additionally, its compatibility with green chemistry principles has been noted, as it can be synthesized using relatively benign reagents and conditions compared to some traditional organic transformations.

The compound’s applications extend beyond pharmaceuticals into the realm of materials science. For example, researchers have explored its use as an additive in polymer formulations to improve flexibility or thermal stability. The long hydrophobic chain can interact with polymer backbones, altering their physical properties while maintaining biocompatibility. Such applications could lead to new materials with enhanced performance characteristics suitable for medical devices or biodegradable packaging.

As interest in personalized medicine grows, 1-o-hexadecyl-2-o-methyl-rac-glycerol may find utility in customized drug formulations tailored to individual patient needs. Its ability to enhance drug solubility and targeting could be leveraged to develop treatments that address specific genetic or metabolic variations among patients. This aligns with broader trends in precision healthcare, where compounds like this could play a pivotal role in optimizing therapeutic outcomes.

The regulatory landscape for such compounds is also evolving, with increasing emphasis on safety and efficacy evaluations before clinical translation. Given these considerations, further preclinical studies are warranted to establish dosing guidelines and long-term safety profiles for 1-o-hexadecyl-2-o-methyl-rac-glycerol before it can be considered for human trials. Collaborative efforts between academic researchers and industry partners will be essential to accelerate this process.

In conclusion,1-o-hexadecyl-2-o-methyl-rac-glycerol (CAS No. 111188-59-1) represents a versatile compound with diverse applications across pharmaceuticals, biochemical research, and materials science. Its unique structural features offer opportunities for innovation in drug delivery systems, lipid metabolism studies, and advanced material formulations. While challenges remain regarding regulatory approval and large-scale synthesis, this compound holds significant promise as a tool for addressing complex biological challenges.

• 41107-82-8(2,5-Anhydro-D-mannitol)
• 5306-85-4(Isosorbide dimethyl ether)
• 652-67-5(Isosorbide)
• 27826-73-9(2,5-Anhydro-D-glucitol)
• 544-62-7(Batyl alcohol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)